301301 川寧生物
按盤價 
12.260 +0.310 (+2.594%)
12.260 +0.310 (+2.594%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.938 | 14.289 | 7.499 | 2.361 | 5.038 |
| 總資產報酬率 ROA (%) | 3.405 | 9.163 | 4.146 | 1.149 | 2.311 |
| 投入資產回報率 ROIC (%) | 3.751 | 9.985 | 4.487 | 1.243 | 3.265 | 邊際利潤分析 |
| 銷售毛利率 (%) | 34.419 | 31.574 | 24.798 | 22.213 | 21.590 |
| 營業利潤率 (%) | 27.785 | 23.249 | 14.268 | 6.919 | 7.635 |
| 息稅前利潤/營業總收入 (%) | 28.531 | 24.434 | 15.983 | 9.649 | 12.521 |
| 淨利潤/營業總收入 (%) | 23.150 | 19.500 | 10.771 | 3.445 | 6.275 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 100.630 | 105.081 | 118.651 | 169.124 | 99.022 |
| 價值變動淨收益/利潤總額(%) | -0.850 | -1.318 | -1.837 | 2.898 | 0.755 |
| 營業外收支淨額/利潤總額(%) | -0.310 | -0.330 | -11.790 | -66.783 | -0.932 | 償債能力分析 |
| 流動比率 (X) | 1.761 | 1.560 | 1.672 | 1.255 | 1.381 |
| 速動比率 (X) | 1.213 | 0.899 | 1.161 | 0.688 | 0.778 |
| 資產負債率 (%) | 30.648 | 31.220 | 40.229 | 49.508 | 52.966 |
| 帶息債務/全部投入資本 (%) | 20.704 | 21.568 | 35.033 | 44.967 | 49.241 |
| 股東權益/帶息債務 (%) | 369.009 | 349.970 | 184.124 | 121.635 | 102.908 |
| 股東權益/負債合計 (%) | 225.890 | 219.900 | 148.436 | 101.858 | 88.685 |
| 利息保障倍數 (X) | 34.308 | 19.374 | 4.964 | 1.754 | 2.526 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 46.368 | 60.668 | 78.132 | 89.692 | 100.670 |
| 存貨周轉天數 (天) | 136.815 | 166.893 | 177.739 | 207.786 | 180.590 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 05/07/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
